| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
-0.27 |
0.05 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
0.28 |
0.05 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |